Talaris Therapeutics Announces Second Quarter Financial Results and Corporate Update
15.08.2022 - All FREEDOM-1 patients who received FCR001 at least three months prior to the data cutoff date of June 15, 2022 had achieved and maintained
Source: wallstreet-online.de